Differences in outcomes between patients with early Alzheimer’s disease who used lecanemab and matched controls increased ...

Experienced commercial leader to shape launch strategy and global market readiness for telitacicept and future pipeline ...

Biogen’s Qalsody (tofersen) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) as the first ...

Genetic testing company Myriad Genetics (NASDAQ:MYGN) will be announcing earnings results this Tuesday after market hours.

Marcus Evans announces the PharmaPack Summit 2025, an invitation-only event dedicated to the leaders defining the future of pharmaceutical packaging.

Sage Therapeutics, Inc. (Nasdaq: SAGE), today reported business highlights and financial results for the second quarter ended June 30, 2025.